- Home
- AMTD vs ANEB Comparison
AMTD vs ANEB Comparison
Compare AMTD & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTD
- ANEB
- Stock Information
- Founded
- AMTD 2003
- ANEB 2020
- Country
- AMTD France
- ANEB United States
- Employees
- AMTD N/A
- ANEB N/A
- Industry
- AMTD
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- AMTD
- ANEB Health Care
- Exchange
- AMTD Nasdaq
- ANEB Nasdaq
- Market Cap
- AMTD 93.9M
- ANEB 98.6M
- IPO Year
- AMTD 2019
- ANEB 2021
- Fundamental
- Price
- AMTD $1.10
- ANEB $2.35
- Analyst Decision
- AMTD
- ANEB Buy
- Analyst Count
- AMTD 0
- ANEB 2
- Target Price
- AMTD N/A
- ANEB $8.00
- AVG Volume (30 Days)
- AMTD 37.3K
- ANEB 100.5K
- Earning Date
- AMTD 04-30-2025
- ANEB 11-12-2025
- Dividend Yield
- AMTD N/A
- ANEB N/A
- EPS Growth
- AMTD N/A
- ANEB N/A
- EPS
- AMTD 0.76
- ANEB N/A
- Revenue
- AMTD $67,032,000.00
- ANEB N/A
- Revenue This Year
- AMTD N/A
- ANEB N/A
- Revenue Next Year
- AMTD N/A
- ANEB N/A
- P/E Ratio
- AMTD $1.48
- ANEB N/A
- Revenue Growth
- AMTD N/A
- ANEB N/A
- 52 Week Low
- AMTD $0.92
- ANEB $0.80
- 52 Week High
- AMTD $1.54
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- AMTD 44.61
- ANEB 45.10
- Support Level
- AMTD $1.22
- ANEB $2.23
- Resistance Level
- AMTD $1.22
- ANEB $2.39
- Average True Range (ATR)
- AMTD 0.07
- ANEB 0.10
- MACD
- AMTD -0.02
- ANEB -0.01
- Stochastic Oscillator
- AMTD 0.00
- ANEB 26.45
About AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.